Aug 14, 2019 / 01:00PM GMT
Heikki Lanckriet - Expedeon AG - CEO, Chief Scientific Officer & Member of Management Board
Thank you very much, Kevin, and welcome, everybody, to our half yearly conference call where we're going to report to you about the progress we've made in the first half of 2019.
As mentioned today on the call, there's myself, Heikki Lanckriet, CEO; and I've got David Roth, our CFO in the room as well. Before we start off -- before we start off, the usual disclaimer. So I'll give you a quick minute to read this. And then we can move on to today's agenda.
So I will give you a quick company overview and a brief operational review. I won't go into too much detail because I want to give as much time as possible to David to go into the financial details of the half yearly report, and then we'll finish off with an outlook for the rest of the year.
So starting off then with the company review. For those of you who have been following us for a few years now, you've seen that we've gone through quite a transition where we've been executing our grow, buy, build strategy. So over the past 3
Q2 2019 Expedeon AG Earnings Call (German) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot